Clinical Trial Update: GeneXpert Performance Evaluation for Linkage to Tuberculosis Care [NA]

View source ↗

Summary

Clinical trial update reporting results of evaluating GeneXpert performance for linkage to tuberculosis care, including pulmonary TB and rifampicin-resistant TB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rifampicin-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• GeneXpert MTB/RIF (Xpert MTB/RIF assay)

Snippet

Sponsor: University of California, San Francisco | Conditions: Tuberculosis, Pulmonary, Rifampicin Resistant Tuberculosis | NA | Status: COMPLETED | Results posted: 2025-02-18